EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Feasibility for non‐invasive prenatal fetal blood group and platelet genotyping by massively parallel sequencing: A single test system for multiple atypical red cell, platelet and quality control markers

Eunike C McGowan iD, Helen O'Brien iD, Mia E Sarri iD, Genghis H Lopez iD, James J Daly iD, Robert L Flower iD, Glenn J Gardener iD, Catherine A Hyland iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Eunike C McGowan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia. Hauptthemen laut MEDLINE: Blood Group Antigens, Antigens, Human Platelet. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Australian Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐invasive prenatal tests (NIPT) to predict fetal red cell or platelet antigen status for alloimmunised women are provided for select antigens. This study reports on massively parallel sequencing (MPS) using a red cell and platelet probe panel targeting multiple nucleotide variants, plus individual identification single nucleotide polymorphisms (IISNPs). Maternal blood samples were provided from 33 alloimmunised cases, including seven with two red cell antibodies. Cell‐free and genomic DNA was sequenced using targeted MPS and bioinformatically analysed using low‐frequency variant detection. The resulting maternal genomic DNA allele frequency was subtracted from the cell‐free DNA counterpart. Outcomes were matched against validated phenotyping/genotyping methods, where available. A 2.5% subtractive allele frequency threshold was set after comparing MPS predictions for K, RhC/c, RhE/e and Fy a /Fy b against expected outcomes. This threshold was used for subsequent predictions, including HPA‐15a, Jk a /Jk b , Kp a /Kp b and Lu a . MPS outcomes were 97.2% concordant with validated methods; one RhC case was discordantly negative and lacked IISNPs. IISNPs were informative for 30/33 cases as controls. NIPT MPS is feasible for fetal blood group genotyping and covers multiple blood groups and control targets in a single test. Noting caution for the Rh system, this has the potential to provide a personalised service for alloimmunised women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Group AntigensAntigens, Human PlateletPregnancyHumansFemaleFetal BloodGenotypeFeasibility StudiesPrenatal DiagnosisDNAHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

NIPTalloimmunisationblood groupscell-free DNAsequencing

Substanzen

Blood Group AntigensDNAAntigens, Human Platelet

Autor:innen und Institutionen

  • Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.
  • Red Cell Reference Laboratory, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.
  • School of Health, University of the Sunshine Coast, Sippy Downs, Queensland, Australia.
  • Pathology Services, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.
  • School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Maternal Fetal Medicine, Mater Mothers' Hospital, South Brisbane, Queensland, Australia.

ORCID-Profile: Eunike C McGowan, Helen O'Brien, Mia E Sarri, Genghis H Lopez, James J Daly, Robert L Flower, Glenn J Gardener, Catherine A Hyland

Förderung

  • Australian Government

Zitieren

APA

McGowan, E. C., O'Brien, H., Sarri, M. E., Lopez, G. H., Daly, J. J., Flower, R. L., Gardener, G. J., & Hyland, C. A. (2024). Feasibility for non‐invasive prenatal fetal blood group and platelet genotyping by massively parallel sequencing: A single test system for multiple atypical red cell, platelet and quality control markers. British Journal of Haematology. https://doi.org/10.1111/bjh.19197

Vancouver

McGowan EC, O'Brien H, Sarri ME, Lopez GH, Daly JJ, Flower RL, et al. Feasibility for non‐invasive prenatal fetal blood group and platelet genotyping by massively parallel sequencing: A single test system for multiple atypical red cell, platelet and quality control markers. British Journal of Haematology. 2024. doi:10.1111/bjh.19197

BibTeX
@article{McGowan2024,
  author = {McGowan, Eunike C and O'Brien, Helen and Sarri, Mia E and Lopez, Genghis H and Daly, James J and Flower, Robert L and Gardener, Glenn J and Hyland, Catherine A},
  title = {Feasibility for non‐invasive prenatal fetal blood group and platelet genotyping by massively parallel sequencing: A single test system for multiple atypical red cell, platelet and quality control markers},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19197}
}
Kostenlos starten →